CAROLINE KUDRICH: Open Payments
NPI 1861275919 · NANTICOKE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,733 in 161 payments from 27 companies in 2025. Trend: 2023 $0 · 2024 $1,230 · 2025 $2,733
Food & beverage: $2,733
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $454 |
| PFIZER INC. | 19 | $274 |
| Amgen Inc. | 19 | $246 |
| Novo Nordisk Inc | 14 | $231 |
| Lilly USA, LLC | 12 | $181 |
| Otsuka America Pharmaceutical, Inc. | 11 | $175 |
| AstraZeneca Pharmaceuticals LP | 8 | $172 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $94 |
| Lundbeck LLC | 5 | $89 |
| Kowa Pharmaceuticals America, Inc. | 5 | $87 |
Products named: REXULTI, UBRELVY, OTEZLA, QULIPTA, JARDIANCE, MOUNJARO, Wegovy, NURTEC ODT.
Industry payments across PA — which companies pay providers there.
